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A B S T R A C T
Approaches based on genetic modiﬁcation have been invaluable for investigating a wide array of biological
processes, with gain- and loss-of-function approaches frequently used to investigate gene function. However,
the presence of paralogues, and hence possible genetic compensation, for many genes necessitates the knockout
(KO) of all paralogous genes in order to observe clear phenotypic change. CRISPR technology, the most recently
described tool for gene editing, can generate KOs with unprecedented ease and speed and has been used in adult
stem cell-derived organoids for single gene knockout, gene knock-in and gene correction. However, the
simultaneous targeting of multiple genes in organoids by CRISPR technology has not previously been described.
Here we describe a rapid, scalable and cost eﬀective method for generating double knockouts in organoids. By
concatemerizing multiple gRNA expression cassettes, we generated a ‘gRNA concatemer vector’. Our method
allows the rapid assembly of annealed synthetic DNA oligos into the ﬁnal vector in a single step. This approach
facilitates simultaneous delivery of multiple gRNAs to allow up to 4 gene KO in one step, or potentially to
increase the eﬃciency of gene knockout by providing multiple gRNAs targeting one gene. As a proof of concept,
we knocked out negative regulators of the Wnt pathway in small intestinal organoids, thereby removing their
growth dependence on the exogenous Wnt enhancer, R-spondin1.
1. Introduction
It was discovered almost 70 years ago that DNA is the genetic
material (Steinman and Moberg, 1994), and from that time onwards
molecular genetics has made and continues to make essential con-
tributions to our biological understanding of health and disease. Today,
gain-of-function and loss-of-function approaches are frequently used to
investigate gene function. CRISPR technology represents the most
recent advance in gene editing tools and has revolutionized the speed
and ease of genetic manipulation in diverse organisms.
Using CRISPR technology, double-strand breaks (DSBs) can be
generated by the Cas9 endonuclease following its targeting to the
desired genomic site under the guidance of a single stranded ‘guide’
RNA molecule (gRNA). Cas9-induced DSBs then activate the cell's
endogenous DNA repair machinery, resulting in genetic repair either
via the error-prone Non-Homologous End-Joining pathway (NHEJ) or
via high-ﬁdelity Homologous Recombination (HR). The latter allows
the precise introduction of a desired nucleotide sequence (Cho et al.,
2013; Cong et al., 2013; Jinek et al., 2013; Mali et al., 2013).
To date, genome-wide genetic knockout (KO) screens in ﬂies,
zebraﬁsh, mice and human cells have been performed (Bassett et al.,
2015; Chelouﬁ et al., 2015; Koike-Yusa et al., 2014; Leeb et al., 2014;
Mali et al., 2013; Shah et al., 2015). These screens, although
comprehensive, are based on the use of one or more gRNAs per gene,
and the transduction of one cell with one single gRNA. This type of
screen can be used to identify novel gene functions, but relies on
phenotypic change being triggered by the deletion of a single gene. In
the mammalian genome, a large number of genes have paralogues that
are generated via gene duplication event(s) with potentially similar
function (Jensen, 2001; Nehrt et al., 2011). Thus, single gene KO may
not result in a clear phenotype due to the existence of functionally
similar paralogue(s), a phenomenon known as genetic compensation.
In order to negate such compensation it is necessary to knockout the
gene of interest as well as its paralogue(s) to observe a clear phenotypic
change. On a small scale this can be achieved by consecutive or
simultaneous delivery of multiple gRNA vectors, but for larger scale
approaches both the vector cloning and delivery has to be optimized.
To circumvent this problem, gRNA cassette multiplexing into one
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vector has been developed by many groups for mammalian systems
(Albers et al., 2015; Kabadi et al., 2014; Maddalo et al., 2014; Sakuma
et al., 2014; Vad-Nielsen et al., 2016; Wyvekens et al., 2014) as well as
Drosophila (Port et al., 2014), E. coli (Cress et al., 2015), plants (Xie
et al., 2015; Ma et al., 2015; Xing et al., 2014) and zebraﬁsh (Yin et al.,
2015). Golden gate cloning, based on the combination of Type II
restriction enzymes and DNA ligase, is a popular cloning strategy used
to multiplex gRNAs. Type II restriction enzymes can generate non-
palindromic overhangs by cutting outside of their recognition se-
quence: this permits the assembly of multiple DNA fragments each
with diﬀerent overhang sequences (Engler et al., 2009). In this method,
however, gRNAs are ﬁrst cloned into individual vectors which are later
combined into one ﬁnal vector, thus requiring two cloning steps.
Here we report a cloning method allowing the assembly of multiple
gRNAs in one single step, thus eliminating the need for additional
cloning steps. Using small intestinal organoids, we generated double-
mutant organoids with constitutively active Wnt signaling by knocking
out all of the paralogues of key negative regulators in the Wnt signaling
pathway.
2. Materials and methods
2.1. Cloning of the concatemer vector
2.1.1. Cloning of backbone vectors with Bbs1 sites
The empty gRNA vector (41824, Addgene) was obtained from
Addgene and used as a template for inverse PCR (Phusion DNA
polymerase, M0530S, NEB) in order to incorporate two BbsI cloning
sites into the vector. For the inverse PCR, two primers were used: one
primer (TTTTAGAGCTAGAAATAGCAAGTTAAAATAAGG) going in the
forward direction was phosphorylated at the 5′ end while the other
primer (Cassette 1: CGTCTTCTCGAAGACCCGGTGTTTCGTCCTTT
CCACAAGAT, Cassette 2: CTGTCTTCTCGAAGACTCCGGTGTTT
CGTCCTTTCCACAAGAT, Cassette 3: CTTGTCTTCTCGAAGACTTCC
GGTGTTTCGTCCTTTCCACAAGAT, and Cassette 4: GTCTTCTC
GAAGACCGGTGTTTCGTCCTTTCCACAAGAT) carried two inversely
located BbsI sites. Subsequent DpnI treatment removed remaining
methylated template vector before ligation and transformation into
10 G competent bacterial cells (60108-1, Cambridge Bioscience). The
modiﬁed gRNA expression vectors containing BbsI sites were trans-
formed and isolated using a Qiagen spin miniprep kit (27106, Qiagen).
These vectors were used as templates for the PCR ampliﬁcation of each
‘cassette’ unit. The forward primer (AGATCTCCAAGGT
CGGGCAGGAAGAGG) contains a BglII site in the overhang, binds to
the upstream region of the U6 promoter and is common for all cassette
units while the reverse primer (Cassette 1: GTCGACGAATTCGG
ATCCTTGTCATCGTCGTCCTTGTAGTCAAAAAAGCACCGACTCGGTG-
CCAC, Cassette 2: GTCGACGAATTCGGATCCGGCGTAGTCGGG
CACGTCGTAGGGGTAAAAAAGCACCGACTCGGTGCCAC, Cassette 3:
GTCGACGAATTCGGATCCCAGGTCCTCCTCTGAGATCAGCTTCTGCA-
TTGATGCCATAAAAAAGCACCGACTCGGTGCCAC, and Cassette 4:
GTCGACGAATTCGGATCCAAAAAAGCACCGACTCGGTGCCAC) binds
to the 3′ end. Each reverse primer has a unique overhang, providing
both a primer binding site for Sanger sequencing and recognition sites
for the three restriction enzymes – BamHI, EcoRI and SalI. Each PCR-
ampliﬁed cassette unit was cloned into the Pjet1.2 vector
(ThermoFisher Scientiﬁc, K131). Using the vector containing the ﬁrst
cassette, the other three cassette units were added sequentially by
digesting the destination vector with BamHI (R0136, NEB) and SalI
(R3138, NEB) and the cassette to be inserted with BglII (R0144, NEB)
and SalI. This generated four diﬀerent vectors containing; ‘Cassette 1’,
‘Cassette 1–2’, ‘Cassette 1–3’ and ‘Cassette 1–4’. The assembled
cassette units were subsequently moved to the retroviral expression
vector MSCV-puro (631461, Clontech) by restriction digestion using
BglII and EcoRI (R0101, NEB).
2.1.2. Multiple gRNA cloning
gRNAs were ordered as oligonucleotides (oligos) from Sigma
Aldrich. Each oligo was composed of the 5′ and 3′ overhangs speciﬁc
for the cassette into which the gRNA would be inserted as well as the
gRNA sequence of choice (Table 1 and Supplementary Table 1). gRNAs
with a low number of potential oﬀ-target sites were identiﬁed using the
bioinformatics tool developed by the Zhang lab (http://crispr.mit.edu/
). For each gRNA, two oligos corresponding to the sense and antisense
sequence were ordered. Oligos were then mixed, phosphorylated and
annealed in a single reaction using 10 µm of each oligo, T4 DNA ligase,
T4 PNK and water in a 20 µl reaction with the following thermocycler
settings; 37 °C for 30 min, 95 °C for 5 min, ramp down to 25 °C at 0.
3 °C/min and 4 °C.
Golden gate cloning for 1 and 2 gRNAs was performed as previously
described (Ran et al., 2013). For 3 and 4 gRNAs, the annealed and
phosphorylated oligos were diluted 1:100 prior to Golden gate cloning
using the following thermocycler settings; ﬁrst 37 °C for 5 min and
21 °C for 5 min for 50 cycles, then 37 °C for 5 min and 4 °C. Treatment
with Plasmid-safe (E3101K, Cambio) is optional but highly recom-
mended to avoid false positive clones. The reaction mix was then
transformed into 10 G bacteria (60108-1, Cambridge Bioscience) and
candidate plasmids were isolated using a Qiagen midi prep kit (12145,
Qiagen). Correctly assembled gRNA concatemers were identiﬁed by
screening using BglII and EcoRI digestion and subsequent conﬁrma-
tion by Sanger sequencing.
2.2. Transfection of small intestinal organoids
Organoid transfection has previously been described (Schwank
et al., 2013). In brief, prior to transfection organoids were cultured
in Wnt3a-containing media supplemented with nicotinamide until they
showed a cystic morphology. For transient transfection, 3–4 high
density wells of a 48-well plate were collected into an Eppendorf tube
and mechanically disrupted. Organoids were dissociated into single
cells by treatment with TrypLE Express (12605010, Invitrogen), spun
down and resuspended in 100 µl media without antibiotics (Advanced
DMEM/F12 supplemented with 10 mM Hepes, Glutamax, 1× N2, 1×
B27 (all from Invitrogen), and 1 µm N-acetylcysteine (Sigma) and
containing the growth factors and inhibitors: 50 ng/ml EGF, 100 ng/ml
noggin, CHIR99021 and Y-27632). For the transfection, 4 µl of
Lipofectamine 2000 (11668019, Invitrogen) and a total amount of
1.6 µg of DNA (Cas9:concatemer in a 1:1 ratio) were added to separate
tubes containing 50 µl Opti-MEM I Reduced Serum Medium
(31985062, Gibco) and incubated separately for 5 min at room
temperature before being pooled and incubated together for a further
25 min. Following addition of the Lipofectamine-DNA mixture to the
single cell solution in one well of a 48-well plate, the plate was spun at
600×g for 1 h at 32 °C and then incubated at 37 °C in a tissue culture
incubator for 6 h. Finally, the DNA-cell mixture was collected and spun
down at 500×g for 5 min. The supernatant was removed and the cell
pellet was resuspended in Matrigel (356231, Corning) and seeded into
one well of a 48-well plate. Transfected organoids were cultured for 2–
3 days before selection was started. Selection was performed in the
organoid culture media without R-spondin1.
Table 1
Sequence of the customized overhangs for cloning into the different cassettes.
Cassette 1 Cassette 2 Cassette 3 Cassette 4
Sequence 5′ to
3′
CACCGG
[target]GT
ACCGG
[target]G
CCGG
[target]
ACACCGG
[target] GTT
Sequence 5′ to
3′
TAAAAC[rc-
target]CC
AAAAC[rc-
target]C
A AAC[rc-
target]
CTAAAAC[rc-
target]CCG
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2.3. Small intestinal organoid culture
2.3.1. Culture media
Murine small intestinal organoids were isolated and cultured as
previously described (Sato et al., 2009).
2.3.2. Picking of small intestinal organoids
Matrigel was gently disrupted by pipetting and transferred together
with the media to a 35 mm dish (121 V, Thermoﬁsher Scientiﬁc).
Single organoids were picked under a light microscope, collected in
Eppendorf tubes and then mechanically disrupted and seeded in
Matrigel in a single well of a 48-well plate (CLS3548-100EA,
Qiagen). Selection media was overlaid in the well once the Matrigel
had solidiﬁed.
2.4. Sequencing
For sequencing, one single well of a 48-well plate of organoids
derived from a single organoid clone was collected and mechanically
disrupted. The organoid fragments were spun down at 600×g for 5 min
at room temperature. The supernatant was removed and the pellet was
resuspended in DirectPCR Lysis Reagent Ear (402-E, Viagen Biotech)
and incubated at 60 °C for 3–5 h.
The DNA-lysis mix was diluted 1:10 and used as template for PCR
ampliﬁcation using Phusion DNA polymerase of the area surrounding
the gRNA target region. The PCR product was cloned into Pjet1.2 and
transformed into 10G competent bacteria (60108-1, Cambridge
Bioscience). A minimum of 5 colonies were picked for each organoid
clone and plasmid DNA was isolated from each of these colonies using
a Qiagen spin miniprep kit (27106, Qiagen) to allow Sanger sequen-
cing.
3. Results
3.1. Generation of a single ‘concatemer’ vector for multiple gRNA
expression
Paralogues are genes within the same genome related by duplica-
tion (Jensen, 2001) and their presence makes it desirable to knockout
multiple genes simultaneously in order to negate redundancy which
may otherwise mask corresponding phenotypic changes by genetic
compensation. Simultaneous knockout of several genes using CRISPR
technology requires the eﬃcient delivery of multiple gRNAs and Cas9.
On a small scale this can be achieved by co-transfection of multiple
gRNA plasmids or in vitro transcribed mRNAs. However, for a large
scale screen and systems with low transfection eﬃciency it is desirable
to have a single vector containing multiple gRNA cassettes.
To generate a single vector which allows the simultaneous expres-
sion of multiple gRNAs, the gRNA expression cassette with two
inversely located BbsI sites at the target sequence cloning site was
concatemerized and cloned into the MSCV retroviral vector as de-
scribed in ‘Section 2’ (2.1 Cloning of the concatemer vector). As a
result, the four gRNA expression cassettes were combined into single
MSCV vectors containing either one (‘Cassette 1’), two (‘Cassette 1–2’),
three (‘Cassette 1–3’) or four (‘Cassette 1–4’) cassettes (Supplementary
Fig. 1A).
Simultaneous cloning of multiple gRNAs into the concatemer vector
is based on the unique, custom-designed overhangs of each individual
gRNA expression cassette. gRNA oligos are ordered with overhangs
matching that of the target cassette and can be annealed in a single
reaction or multiple individual reactions (Table 1). Annealed oligos are
cloned into the concatemer vector by Golden gate assembly, where
continuous cycles of digestion and ligation facilitate incorporation of
the gRNAs into the correct cassette, so resulting in the ﬁnal vector
(Fig. 1).
Cloning of gRNAs into the ‘Cassette 1’ and ’Cassette 1–2’ con-
catemer vectors worked eﬃciently with previously described protocols
(Ran et al., 2013) but for the eﬃcient simultaneous insertion of 3 or 4
gRNAs, conditions were optimized to include a vector:insert ratio of
1:5 and an increased number of cycles for Golden gate assembly. Using
this optimized protocol, multiple gRNAs were cloned into the ‘Cassette
1–3’ or ‘Cassette 1–4’ with at least 25% eﬃciency (Supplementary
Table 1). Successful gRNA integration was conﬁrmed by restriction
digestion. When performing restriction digestion with BglII and EcoRI,
expected band sizes correspond to the number of expression cassettes,
with the size of a single cassette being ~400 bp (Supplementary
Fig. 1A,B). Additional restriction using BbsI allows detection of false
positives, as successful gRNA insertion destroys the BbsI site of the
expression cassette, thus inhibiting digestion (Supplementary Fig. 1B).
3.2. Simultaneous knockout of functionally related paralogues in
small intestinal organoids with the concatemer vector
To validate the use of the concatemer vector we chose primary
mouse small intestinal organoid culture. Although this 3D culture
system is rapidly becoming popular, as it closely resembles the in vivo
tissue, it is still relatively diﬃcult to transfect mouse intestinal
organoids using simple lipofection methods when compared to
HEK293 and mouse embryonic stem cells. Here, we aimed to knock
out paralogues acting as negative regulators of the Wnt signaling
pathway in organoid culture using our concatemer vector system.
The Wnt pathway plays an essential role in the maintenance of
small intestinal stem cells (ISCs) in vitro as well as in vivo (Gregorieﬀ
and Clevers, 2005; Sato et al., 2009). Upon the binding of Wnt to its
receptor Frizzled and co-receptor Lrp5/6 (lipoprotein receptor related
protein 5/6), the activated receptor recruits Dvl (Dishevelled), which
sequesters the destruction complex at the plasma membrane thus
inactivating it. This results in an increased level of β-catenin, which
translocates to the nucleus where it interacts with the Tcf/Lef
transcription factors and induces the transcription of Wnt target genes.
Rnf43 and Znrf3 form another axis of regulation in the Wnt pathway.
These negative feedback regulators are expressed upon Wnt stimula-
tion and prevent prolonged Wnt activation by inhibiting the Frizzled
and Lrp5/6 complex. Upon R-spondin stimulation, Rnf43/Znrf3 are
recruited to the Lgr4/5/6 and R-spondin complex and hence abrogate
this negative feedback loop, resulting in enhanced Wnt activation.
In vitro, removal of the growth factor R-spondin1, a potent Wnt
enhancer, results in rapid death of the cultures within 3–4 days. Only
organoids subject to constitutively active Wnt signaling, for example
following mutation of the Adenomatous polyposis coli (Apc) gene or
treatment with the Glycogen Synthase Kinase 3 (GSK3) inhibitor
(CHIR99021), can survive withdrawal of R-spondin1 (Sato et al.,
2011; Schwitalla et al., 2013; Yin et al., 2014). Thus, small intestinal
organoids represent a sensitive model system in which the simulta-
neous knockout of key Wnt pathway members and their paralogues can
be easily tested by a clear phenotypic readout, namely survival
following R-spondin1 withdrawal. Constitutive Wnt pathway activation
can be achieved by inhibiting the destruction complex consisting of
Apc, GSK3, Axin and CK1 (casein kinase 1) or by disrupting the
negative feedback loop formed by the two E3 ubiquitin ligases Rnf43
and Znrf3 (RZ) (Fig. 2A).
Concatemer vectors were generated for the abovementioned pro-
teins and their paralogues (GSK3α and GSK3β, Axin1 and Axin2, and
RZ). Prior to transfection, organoids were cultured in Wnt3a-contain-
ing media until they adopted a cystic morphology, after which they
were disrupted into fragments containing 1–5 cells and co-transfected
with an equal amount of concatemer vector and Cas9 plasmid
(Addgene, #41815) using Lipofectamine 2000. Importantly, the orga-
noid-DNA mix was spun at 32 °C for 1 h to increase the transfection
eﬃciency. Organoids were cultured in media containing Wnt3a and
ROCK inhibitor for 3 days following transfection, after which selection
was initiated by the removal of R-spondin1 from the culture media.
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Following 10 days of selection, surviving organoid clones were picked,
expanded and genotyped by Sanger sequencing to conﬁrm successful
KO. The recovered organoid clones survived without R-spondin
(Fig. 2B) and showed disruption of both paralogues for Axin1 & 2,
GSKα& β and RZ as appropriate, conﬁrming the functionality of the
concatemer vector (Fig. 2C).
4. Discussion
CRISPR technology has made genome editing both simple and fast
and has facilitated genome-wide knockout screens in mouse and
human cells (Koike-Yusa et al., 2014; Leeb et al., 2014; Wang et al.,
2013). Although powerful, the presence of paralogues might conceal
potential phenotypes when knocking out only single genes. Therefore,
it is desirable to not only knock out the gene of interest but also its
paralogues. Here we present a method allowing the one step generation
of a single concatemer vector simultaneously expressing multiple
gRNAs. Based on Golden gate cloning, this rapid method requires only
one cloning step and the generated vector can immediately be used for
plasmid transfection or retroviral transduction. In addition, gRNAs can
be easily ordered as oligos with customized overhangs. It is of note that
the gRNA sequence should not contain any BbsI recognition sequences,
as this restriction enzyme is used during the vector assembly. The
concatemer method is expected to be compatible with other cell lines
and organoids as long as they can be maintained following single cell
dissociation.
Using the concatemer vector, we demonstrated simultaneous dis-
ruption of genes of the Wnt pathway in the context of small intestinal
organoids, thus allowing organoids to survive in the absence of the Wnt
enhancer R-spondin1. Rnf43/Znrf3 double KO organoids display a
budding morphology compared to Apc, Axin1/2, GSK3α/β which are
round and cystic. This is caused by the Wnt dependency of Rnf43/
Znrf3 double KO organoids, in which buds are formed around Wnt-
secreting Paneth cells. On the other hand, the other mutants exhibit
autonomous Wnt activation due to the lack of a functional destruction
complex, which leads to uniform growth activity and round cystic
organoids. Other potential uses for the concatemer vector include the
cloning of multiple gRNAs targeting one gene into a single vector in
order to increase eﬃciency for wildtype- and nickase-mediated gene
editing, and the generation of a paralogue KO library. Moreover, the
design of the concatemer vector allows the insertion of additional
cassettes (A BglII-SalI concatemer fragment to BamHI and SalI sites of
another concatemer vector, please note that BglII and BamHI are
compatible and their ligation destroys the restriction site) to increase
the number of gRNAs in one concatemer vector. Another alternative to
increase the targeting numbers would be to simply co-transfect multi-
ple concatermers. In summary our approach is a rapid and eﬃcient
alternative for the cloning of multiple gRNAs to allow simultaneous
knock out of multiple genes, here demonstrated using the organoid
system.
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Fig. 1. Schematic image illustrating the Golden gate cloning of multiple gRNAs into the concatemer vector containing 3 gRNA expression cassettes. Annealed
oligos (gRNA targets), DNA ligase and the BbsI restriction enzyme are mixed with the gRNA concatemer vector in a single reaction. Repeated temperature cycles facilitate repeated
digestion (21 °C) and ligation (37 °C). BbsI digestion generates the custom-designed overhangs unique for each cassette. During the ligation, gRNAs are integrated into the vector by
cassette-speciﬁc integration, determined by the matching overhangs of the gRNA and the vector. If the original fragment containing the two BbsI restriction sites is ligated back into the
vector it will again be removed in the following round of digestion. In contrast, upon ligation of a gRNA the BbsI restriction site is disrupted and hence the gRNA cannot be removed
during the following rounds of digestion. Blue – BbsI enzyme, pink – T7 DNA ligase, U6 – U6 promoter, gRNA1.1–1.3 represent diﬀerent gRNAs for the same gene (e.g. gRNA1.1 –
gRNA1 for gene 1).
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Fig. 2. Simultaneous paralogue knockout in small intestinal organoids using gRNA concatemer vectors. (A) Schematic image of the Wnt signaling pathway. In the
absence of Wnt, the destruction complex consisting of Apc (Adenomatous polyposis coli) and Axin, which act as scaﬀolds, together with the two kinases GSK3 (Glycogen synthase kinase
3) and CK1 (Casein Kinase 1) mediates the degradation of β-catenin, resulting in inhibition of Wnt signaling. For more details on the Wnt pathway the reader is advised to refer to the
main text. (B) Representative images of small intestinal organoids in which negative regulators of the Wnt pathway have been knocked out, thus rendering their growth independent of
addition of the Wnt enhancer R-spondin1. DKO – double knockout, EN- Egf- and Noggin-containing medium lacking R-spondin1. 4× scale bar 1000 µm. 10× scale bar 400 µm. (C)
Sequence data conﬁrm that organoids growing in the absence of R-spondin1 contain mutations in Wnt pathway regulators. The Apc knockout has an 148 bp deletion in both alleles. The
Axin1 & 2 double knockout has a deletion of 1 and 2 bp in the alleles of Axin1 and a 278 and 281 bp deletion in the alleles of Axin2. The GSK3 double knockout has a 2 bp insertion in
both alleles of GSK3α and a 2 bp deletion in both alleles of GSK3β. The Rnf43-Znrf3 double knockout has a 2 bp deletion in both alleles of Rnf43 and a 37 and 43 bp deletion in the
alleles of Znrf3. Number next to sequences indicate clone number and allele.
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